神经退行性疾病中的机制及非药物干预在改善神经退行性变及其临床相关表现中的作用:综述
Mechanisms in neurodegenerative disorders and role of non-pharmacological interventions in improving neurodegeneration and its clinical correlates: A review
AI总结:
本综述梳理轻度认知障碍进展为痴呆的病理生理机制,并探讨超声消融、神经反馈等非药物干预通过神经可塑性改善认知与精神症状的作用机制。
摘要:
轻度认知障碍(MCI)进展为痴呆会导致一系列精神疾病,包括抑郁症、心境障碍、精神分裂症等。随着年龄增长,轻度认知障碍导致伤残调整生命年和医疗负担增加。大量针对与阿尔茨海默病相关的轻度认知障碍的药物试验已经失败,这促使人们开发能够阻止疾病进展的药物。然而,一些新型非药物疗法,如淀粉样斑块的超声消融,已促使研究者探索用于治疗轻度认知障碍的非药物干预方式。为了补偿导致共存精神疾病的神经退行性损失,神经反馈疗法也已被证明可通过诱导神经可塑性来改善行为结果。本综述旨在重点阐述轻度认知障碍进展为痴呆的病理生理方面,这些方面可通过非药物干预加以应对,并理解这些干预措施产生效果背后的机制。
英文摘要:
Mild cognitive impairment (MCI) leading to dementia results in a constellation of psychiatric disorders including depression, mood disorders, schizophrenia and others. With increasing age, mild cognitive impairment leads to increased disability-adjusted life-years and healthcare burden. A huge number of drug trials for the treatment of MCI associated with Alzheimer's disease have undergone failure leading to the development of drugs that could avert the progression of the disease. However, some novel non-drug-based therapies like ultrasound ablation of amyloid plaques have influenced researchers to explore the non-pharmacological modalities for the treatment of mild cognitive impairment. To compensate for neurodegenerative loss resulting in coexisting psychiatric disorders, neurofeedback therapy has also been proven to improve behavioural outcomes by inducing neuroplasticity. The aim of the current review is to highlight the pathophysiological aspects of mild cognitive impairment leading to dementia that could be addressed with no pharmacological interventions and to understand the mechanisms behind the effects of these interventions.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。